-+ 0.00%
-+ 0.00%
-+ 0.00%

Shuttle Pharmaceuticals Dismisses Forvis Mazars as Auditor

PUBT·10/22/2026 20:37:35
Listen to the news
Shuttle Pharmaceuticals Dismisses Forvis Mazars as Auditor
  • Shuttle Pharmaceuticals will dismiss auditor Forvis Mazars under a decision approved by its board on October 16, 2026.
  • The dismissal takes effect following filing of the quarterly report for the period ended September 30, 2026.
  • Forvis Mazars’ audit reports for 2025 and 2024 flagged substantial doubt about the company’s ability to continue as a going concern.
  • Disclosed material weaknesses covered financial reporting controls, IT controls and insufficient technical accounting expertise for complex transactions.
  • No accounting or auditing disagreements arose during 2025, 2024 or the subsequent interim period through October 16, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shuttle Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-048112), on October 22, 2026, and is solely responsible for the information contained therein.